These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36846293)

  • 21. Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review.
    Lu C; Shiradkar R; Liu Z
    Chin J Cancer Res; 2021 Oct; 33(5):563-573. PubMed ID: 34815630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
    Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
    Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and post-operative follow-up of pulmonary sclerosing pneumocytoma: A case report.
    Barnes KE; Wile RK; Banks KC; Velotta JB
    Ann Med Surg (Lond); 2022 Dec; 84():104836. PubMed ID: 36582872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing.
    Lei T; Shen M; Deng X; Shi Y; Peng Y; Wang H; Chen T
    Orphanet J Rare Dis; 2022 Oct; 17(1):382. PubMed ID: 36271373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the value of enhanced CT combined with texture analysis in the differential diagnosis of pulmonary sclerosing pneumocytoma and atypical peripheral lung cancer: a feasibility study.
    Luo C; Song Y; Liu Y; Wang R; Gao J; Yue S; Ding C
    BMC Med Imaging; 2022 Feb; 22(1):16. PubMed ID: 35105314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report.
    Jiang G; Zhang M; Tan Q; Lin S; Zeng Y; Liu C; Chen R; Zhou J
    Lung Cancer; 2019 Nov; 137():52-55. PubMed ID: 31546071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics-Guided Precision Medicine Approaches for Colorectal Cancer.
    Quraishi MI
    Front Oncol; 2022; 12():872656. PubMed ID: 35756680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of Plant Productivity in the Post-Genomics Era.
    Thao NP; Tran LS
    Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
    Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
    J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.
    Huang CC; Tsai YF; Liu CY; Chao TC; Lien PJ; Lin YS; Feng CJ; Chiu JH; Hsu CY; Tseng LM
    BMC Cancer; 2021 Feb; 21(1):199. PubMed ID: 33632156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Identification of
    Zhang T; Xu Z; Liu G; Jiang B; de Bock GH; Groen HJM; Vliegenthart R; Xie X
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D.
    Zwirner K; Hilke FJ; Demidov G; Socarras Fernandez J; Ossowski S; Gani C; Thorwarth D; Riess O; Zips D; Schroeder C; Welz S
    Strahlenther Onkol; 2019 Sep; 195(9):771-779. PubMed ID: 31123786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?].
    Leichsenring J; Kazdal D; Ploeger C; Allgäuer M; Endris V; Volckmar AL; Neumann O; Kirchner M; Penzel R; Rempel E; Budczies J; Schirmacher P; Fröhling S; Stenzinger A
    Pathologe; 2019 May; 40(3):235-242. PubMed ID: 31089797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
    Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technical Note: Ontology-guided radiomics analysis workflow (O-RAW).
    Shi Z; Traverso A; van Soest J; Dekker A; Wee L
    Med Phys; 2019 Dec; 46(12):5677-5684. PubMed ID: 31580484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
    Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
    Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer.
    Zhu J
    J Thorac Dis; 2017 Sep; 9(9):2974-2981. PubMed ID: 29221270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.